2024
Quality of Life in Older Adults With Stable Ischemic Heart Disease and Diabetes Mellitus: A Post Hoc Analysis of the BARI 2D Trial
Park D, Jamil Y, Moumneh M, Batchelor B W, Nanna M, Damluji A. Quality of Life in Older Adults With Stable Ischemic Heart Disease and Diabetes Mellitus: A Post Hoc Analysis of the BARI 2D Trial. The American Journal Of Cardiology 2024, 223: 58-69. PMID: 38797195, PMCID: PMC11214881, DOI: 10.1016/j.amjcard.2024.05.016.Peer-Reviewed Original ResearchDuke Activity Status IndexOlder adultsYears of follow-upStable ischemic heart diseaseIntensive medical therapyQoL measuresStatus indexIschemic heart diseaseDistress ratingsOlder adult populationOlder adult patientsBARI 2D trialDiabetes mellitusQuality of lifeQuality-of-lifeHeart diseaseMultivariate linear regressionFollow-upMedical therapyAdult populationQoLCognitive impairmentOlder patientsPost hoc analysisChronic total occlusion
2023
Do Clinical Outcomes and Quality of Life Differ by the Number of Antianginals for Stable Ischemic Heart Disease? Insights from the BARI 2D Trial
Jamil Y, Park D, Verde L, Sherwood M, Tehrani B, Batchelor W, Frampton J, Damluji A, Nanna M. Do Clinical Outcomes and Quality of Life Differ by the Number of Antianginals for Stable Ischemic Heart Disease? Insights from the BARI 2D Trial. The American Journal Of Cardiology 2023, 214: 66-76. PMID: 38160927, PMCID: PMC10923116, DOI: 10.1016/j.amjcard.2023.12.045.Peer-Reviewed Original ResearchStable ischemic heart diseaseAnti-anginal agentIntensive medical therapyIschemic heart diseaseMedical therapyQOL metricsHeart diseaseFindings merit further researchMajor adverse cardiovascular eventsAnti-anginal treatmentBARI 2D trialGreater QoL improvementAdverse cardiovascular eventsMyocardial jeopardy indexCardiovascular eventsCause mortalityCardiovascular endpointsClinical confoundersPatient characteristicsDiabetes mellitusHeart failureTherapy intensityClinical outcomesQOL improvementMyocardial infarctionD-24 | Quality of Life After Revascularization versus Medical Therapy in Older Adults With Stable Ischemic Heart Disease at 5 Year Follow-up in the BARI2D Trial
Park D, Jamil Y, Chongthammakun V, Nanna M, Al Damluji A. D-24 | Quality of Life After Revascularization versus Medical Therapy in Older Adults With Stable Ischemic Heart Disease at 5 Year Follow-up in the BARI2D Trial. Journal Of The Society For Cardiovascular Angiography & Interventions 2023, 2: 100878. DOI: 10.1016/j.jscai.2023.100878.Peer-Reviewed Original Research
2022
Effect of weight loss on recurrence of atrial fibrillation after ablative therapy: a systematic review and meta-analysis
Park D, An S, Murthi M, Kattoor A, Kaur A, Ravi V, Huang H, Vij A. Effect of weight loss on recurrence of atrial fibrillation after ablative therapy: a systematic review and meta-analysis. Journal Of Interventional Cardiac Electrophysiology 2022, 64: 763-771. PMID: 35258752, DOI: 10.1007/s10840-022-01168-2.Peer-Reviewed Original ResearchConceptsRecurrence of AFStudy of patientsHistory of AFAblation therapyAtrial fibrillationWeight lossRate of recurrence of AFSubgroup analysisRecurrence of atrial fibrillationRisk ratioEffects of weight lossSubgroup analysis of studiesLong-term recurrenceLost weightWeight loss groupMethodsAn extensive literature searchSystematic reviewStudies of weight lossConclusionWeight lossLow recurrenceMedical therapyLoss groupResultsEight studiesRecurrenceTherapy